Crenza Pharmaceuticals Private Limited, a active private limited company, was established on 22 May 2017 in Hyderabad, Telangana, India. Engaging in pharma contract r&d within the professional, scientific and technical sector, it holds CIN: U24304TG2017PTC117228. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹50.00 K .
It upholds a compliant status. Employing 31 professional, Its leadership includes Sandhya Pittala (Whole-Time Director), Satyanarayana Pittala (Director). Past directors included Pittala Soumya. It holds ₹5.00 Cr open charges and no settled loans. Its latest AGM occurred on 23 September 2025, with the balance sheet filed on 31 March 2025. It is based at Flot No.A-27P, Apie Balanagar, Hyderabad, Telangana, 500037.
U24304TG2017PTC117228
117228
22 May 2017
₹0.10 M
₹50.00 K
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Crenza Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sandhya Pittala | Whole-Time Director | 22 May 2017 | Current |
| Satyanarayana Pittala | Director | 30 May 2019 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Whole-Time Director | 04 Jun 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Crenza Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 492.29% increase. The company also saw a substantial improvement in profitability, with a 328.84% increase in profit. The company's net worth Soared by an impressive increase of 134.65%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Crenza Pharmaceuticals had a public holding of 1.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹50,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 06 May 2023 | Hdfc Bank Limited | ₹5.00 Cr | Open |
Explore comprehensive loan charge details -
Crenza Pharmaceuticals has a workforce of 31 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Crenza Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Crenza Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Crenza Pharmaceuticals Private Limited last Annual general meeting of members was held on 23 Sep 2025 as per latest MCA records. was recorded as a recent event.
Progress on A charge with Hdfc Bank Limited of Rs. 50.00 M registered on 06 May 2023 with Charge ID 100726780 was modified on 17 Jun 2025. was documented.
Crenza Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad. was recorded as a recent event.
Progress on A charge with Hdfc Bank Limited amounted to Rs. 50.00 M with Charge ID 100726780 was registered on 06 May 2023. was documented.
The activity Satyanarayana Pittala was appointed as a Director was appointed as a Director on 30 May 2019 & has been associated with this company since 6 years 6 months . was completed.
Progress on Sandhya Pittala was appointed as a Whole-time director was appointed as a Whole-time director on 22 May 2017 & has been associated with this company since 8 years 7 months . was documented.
The CIN of Crenza Pharmaceuticals Private Limited is U24304TG2017PTC117228.
Crenza Pharmaceuticals Private Limited is headquartered at Flot No.A-27P, Apie Balanagar, Hyderabad, Telangana, 500037.
Crenza Pharmaceuticals Private Limited was incorporated on 22 May 2017.
The current directors of Crenza Pharmaceuticals Private Limited are
The primary industry of Crenza Pharmaceuticals Private Limited is Professional, Scientific And Technical.
Crenza Pharmaceuticals Private Limited is unlisted.
The authorized capital of Crenza Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹50.00 K .
The compliance status of Crenza Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX